CAS 936563-96-1
:1-((3r)-3-(4-amino-3-(4-phénoxyphényl)-1h-pyrazolo(3,4-d)pyrimidin-1-yl)-1-pipéridinyl)-2-propén-1-one
- (R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one
- 1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one
- 1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one
- 1-{3-[4-Amino-3-(4-phenoxy-phenyl)-pyrazolo[3,4-d]pyrimidin-1-yl]-piperidin-1-yl}-propenone
- 2-Propen-1-one, 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-
- Cra 032765
- Ibrutinib
- Imbruvica
- Jnj 02
- Pci 32765-00
- Pci-32765
- 1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one
- 1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one
- 1-[(3R)-3-[4-AMino-3-(4-phenoxyphenyl)pyrazolo[3, 4-d]pyriMidin-1-yl]piperidin-1-yl]prop-2-en-1-one
- PCI-32765 1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one
- PCI-32765 (Ibrutinib)
- Ibrutinib (PCI-32765)
- 1-{3-[4-Amino-3-(4-phenoxy-phenyl)-pyrazolo[3,4-d]pyrimidin-1-yl]-piperidin-1-yl}-but-3-en-1-one
- Voir plus de synonymes
1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one
CAS :Formule :C25H24N6O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :440.4971Ref: IN-DA003620
1g40,00€5g85,00€10g123,00€1kgÀ demander25g204,00€50g538,00€100gÀ demander500gÀ demander100mg24,00€250mg25,00€Ibrutinib (PCI-32765)
CAS :Formule :C25H24N6O2Couleur et forme :White To Off-White SolidMasse moléculaire :440.51Ibrutinib
CAS :Formule :C25H24N6O2Degré de pureté :≥ 98.0%Couleur et forme :White or almost white powderMasse moléculaire :440.50Ibrutinib
CAS :Ibrutinib (PCI-32765) is an irreversible inhibitor of BTK (IC50: 0.5 nM) that selectively blocks B cell activation.Formule :C25H24N6O2Degré de pureté :98% - 99.95%Couleur et forme :SolidMasse moléculaire :440.5Ibrutinib
CAS :Produit contrôléApplications Ibrutinib is a highly selective Bruton’s tyrosine kinase (Btk) irreversible inhibitor.
References MacGlashan, D., et. al.: Int. Immunol., 11, 475 (2011)Formule :C25H24N6O2Couleur et forme :Off-WhiteMasse moléculaire :440.5Ibrutinib-d4 (Major)
CAS :Produit contrôléApplications Ibrutinib-d4 is the labelled analogue of Ibrutinib (I124970). Ibrutinib is a highly selective Bruton’s tyrosine kinase (Btk) irreversible inhibitor.
References MacGlashan, D., et. al.: Int. Immunol., 11, 475 (2011)Formule :C25H20D4N6O2Couleur et forme :NeatMasse moléculaire :444.52Ibrutinib
CAS :Ibrutinib is a small-molecule inhibitor of Bruton’s tyrosine kinase, a crucial enzyme to the B-cell receptor pathway. Bruton’s tyrosine kinase becomes continuously activated in B-cell cancers and therefore promotes the survival of tumor cells. Ibrutinib binds irreversibly and covalently to a cysteine residue within the ATP-binding site of the enzyme, thus preventing ATP binding and downstream signal transduction. The ability of Ibrutinib to inhibit Bruton’s tyrosin kinase and hence the B-cell receptor pathway it can be used in the treatment of some B cell cancers such as diffuse large B-cell lymphoma (DLBCL) and chronic lymphocytic leukemia (CLL).Formule :C25H24O2N6Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :440.5 g/molIbrutinib - Bio-X ™
CAS :Ibrutinib is a small-molecule inhibitor of Bruton’s tyrosine kinase, a crucial enzyme to the B-cell receptor pathway. Bruton’s tyrosine kinase becomes continuously activated in B-cell cancers and therefore promotes the survival of tumor cells. Ibrutinib binds irreversibly and covalently to a cysteine residue within the ATP-binding site of the enzyme, thus preventing ATP binding and downstream signal transduction. The ability of Ibrutinib to inhibit Bruton’s tyrosin kinase and hence the B-cell receptor pathway it can be used in the treatment of some B cell cancers such as diffuse large B-cell lymphoma (DLBCL) and chronic lymphocytic leukemia (CLL).
Formule :C25H24O2N6Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :440.5 g/mol








